Standardized Analysis of Frequency and Severity of Complications After Robot-assisted Radical Cystectomy
Abstract Background Comprehensive and standardized reporting of adverse events after robot-assisted radical cystectomy (RARC) and urinary diversion for bladder cancer is necessary to evaluate the magnitude of morbidity for this complex operation. Objective To accurately identify and assess postopera...
Gespeichert in:
Veröffentlicht in: | European urology 2012-11, Vol.62 (5), p.806-813 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 813 |
---|---|
container_issue | 5 |
container_start_page | 806 |
container_title | European urology |
container_volume | 62 |
creator | Yuh, Bertram E Nazmy, Michael Ruel, Nora H Jankowski, Jason T Menchaca, Anita R Torrey, Robert R Linehan, Jennifer A Lau, Clayton S Chan, Kevin G Wilson, Timothy G |
description | Abstract Background Comprehensive and standardized reporting of adverse events after robot-assisted radical cystectomy (RARC) and urinary diversion for bladder cancer is necessary to evaluate the magnitude of morbidity for this complex operation. Objective To accurately identify and assess postoperative morbidity after RARC using a standardized reporting system. Design, setting, and participants A total of 241 consecutive patients underwent RARC, extended pelvic lymph node dissection, and urinary diversion between 2003 and 2011. In all, 196 patients consented to a prospective database, and they are the subject of this report. Continent diversions were performed in 68% of cases. Outcome measurements and statistical analysis All complications within 90 d of surgery were defined and categorized by a five-grade and 10-domain modification of the Clavien system. Univariable and multivariable logistic regression analyses were used to identify predictors of complications. Grade 1–2 complications were categorized as minor, and grade 3–5 complications were categorized as major. All blood transfusions were recorded as grade ≥2. Results and limitations Eighty percent of patients (156 of 196 patients) experienced a complication of any grade ≤90 d after surgery. A total of 475 adverse events (113 major) were recorded, with 365 adverse events (77%) occurring ≤30 d after surgery. Sixty-eight patients (35%) experienced a major complication within the first 90 d. Other than blood transfusions given (86 patients [43.9%]), infectious, gastrointestinal, and procedural complications were the most common, at 16.2%, 14.1%, and 10.3%, respectively. Age, comorbidity, preoperative hematocrit, estimated blood loss, and length of surgery were predictive of a complication of any grade, while comorbidity, preoperative hematocrit, and orthotopic diversion were predictive of major complications. The 90-d mortality rate was 4.1%. The main limitation is lack of a control group. Conclusions Analysis of postoperative morbidity following RARC demonstrates a considerable complication rate, though the rate is comparable to contemporary open series that followed similar reporting guidelines. This finding reinforces the need for complete and standardized reporting when evaluating surgical techniques and comparing published series. |
doi_str_mv | 10.1016/j.eururo.2012.06.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1093490143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283812007087</els_id><sourcerecordid>1093490143</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-f0b8f984b9fb5b1b05821bfbd8b5cbc943aeb416fdaa41aab4ce7d4d59c8bc263</originalsourceid><addsrcrecordid>eNqFkk2LFDEQhoMo7uzqPxDpi-Cl20rSH-mLMAyuKywIO3oO-cSMPZ0x6V5of73VzKjgxVMIed5K5UkR8opCRYG27w6Vm9OcYsWAsgraCqB7QjZUdLzsmhaekg1wYCUTXFyR65wPAMCbnj8nV4x10HDBNuTbflKjVcmGn84W21ENSw65iL64Te7H7EazFAgUe_foUpiW9WQXj6chGDWFOOZi6yeXioeo41SqjOEJCz0oi8BQ7BbcmikelxfkmVdDdi8v6w35evvhy-6uvP_88dNue1-ahvKp9KCF70Wte68bTTU0glHttRW6Mdr0NVdO17T1VqmaKqVr4zpb26Y3QhvW8hvy9lz3lCL2nyd5DNm4YVCji3OWFHpe90Brjmh9Rk2KOSfn5SmFo0oLQnJ1LA_y7FiujiW0Eh1j7PXlhlkfnf0T-i0VgTcXQGWU4JMaTch_ubbmXQcCufdnzqGPx-CSzCagcWdDQmnSxvC_Tv4tYIYwruK_u8XlQ5wTfii-WWbMyP06D-s4UIZpwEH5BZuts9E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1093490143</pqid></control><display><type>article</type><title>Standardized Analysis of Frequency and Severity of Complications After Robot-assisted Radical Cystectomy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yuh, Bertram E ; Nazmy, Michael ; Ruel, Nora H ; Jankowski, Jason T ; Menchaca, Anita R ; Torrey, Robert R ; Linehan, Jennifer A ; Lau, Clayton S ; Chan, Kevin G ; Wilson, Timothy G</creator><creatorcontrib>Yuh, Bertram E ; Nazmy, Michael ; Ruel, Nora H ; Jankowski, Jason T ; Menchaca, Anita R ; Torrey, Robert R ; Linehan, Jennifer A ; Lau, Clayton S ; Chan, Kevin G ; Wilson, Timothy G</creatorcontrib><description>Abstract Background Comprehensive and standardized reporting of adverse events after robot-assisted radical cystectomy (RARC) and urinary diversion for bladder cancer is necessary to evaluate the magnitude of morbidity for this complex operation. Objective To accurately identify and assess postoperative morbidity after RARC using a standardized reporting system. Design, setting, and participants A total of 241 consecutive patients underwent RARC, extended pelvic lymph node dissection, and urinary diversion between 2003 and 2011. In all, 196 patients consented to a prospective database, and they are the subject of this report. Continent diversions were performed in 68% of cases. Outcome measurements and statistical analysis All complications within 90 d of surgery were defined and categorized by a five-grade and 10-domain modification of the Clavien system. Univariable and multivariable logistic regression analyses were used to identify predictors of complications. Grade 1–2 complications were categorized as minor, and grade 3–5 complications were categorized as major. All blood transfusions were recorded as grade ≥2. Results and limitations Eighty percent of patients (156 of 196 patients) experienced a complication of any grade ≤90 d after surgery. A total of 475 adverse events (113 major) were recorded, with 365 adverse events (77%) occurring ≤30 d after surgery. Sixty-eight patients (35%) experienced a major complication within the first 90 d. Other than blood transfusions given (86 patients [43.9%]), infectious, gastrointestinal, and procedural complications were the most common, at 16.2%, 14.1%, and 10.3%, respectively. Age, comorbidity, preoperative hematocrit, estimated blood loss, and length of surgery were predictive of a complication of any grade, while comorbidity, preoperative hematocrit, and orthotopic diversion were predictive of major complications. The 90-d mortality rate was 4.1%. The main limitation is lack of a control group. Conclusions Analysis of postoperative morbidity following RARC demonstrates a considerable complication rate, though the rate is comparable to contemporary open series that followed similar reporting guidelines. This finding reinforces the need for complete and standardized reporting when evaluating surgical techniques and comparing published series.</description><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2012.06.007</identifier><identifier>PMID: 22705382</identifier><identifier>CODEN: EUURAV</identifier><language>eng</language><publisher>Kidlington: Elsevier B.V</publisher><subject>Aged ; Biological and medical sciences ; Bladder cancer ; Blood Transfusion ; Chi-Square Distribution ; Comorbidity ; Complications ; Cystectomy ; Cystectomy - adverse effects ; Cystectomy - methods ; Cystectomy - mortality ; Female ; Humans ; Incidence ; Logistic Models ; Lymph Node Excision - adverse effects ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Nephrology. Urinary tract diseases ; Postoperative Complications - diagnosis ; Postoperative Complications - epidemiology ; Postoperative Complications - mortality ; Postoperative Complications - therapy ; Research Design - standards ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Robotic ; Robotics ; Severity of Illness Index ; Surgery, Computer-Assisted - adverse effects ; Surgery, Computer-Assisted - mortality ; Time Factors ; Treatment Outcome ; Tumors of the urinary system ; Urinary Bladder Neoplasms - mortality ; Urinary Bladder Neoplasms - surgery ; Urinary Diversion - adverse effects ; Urinary system involvement in other diseases. Miscellaneous ; Urinary tract. Prostate gland ; Urology</subject><ispartof>European urology, 2012-11, Vol.62 (5), p.806-813</ispartof><rights>European Association of Urology</rights><rights>2012 European Association of Urology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-f0b8f984b9fb5b1b05821bfbd8b5cbc943aeb416fdaa41aab4ce7d4d59c8bc263</citedby><cites>FETCH-LOGICAL-c513t-f0b8f984b9fb5b1b05821bfbd8b5cbc943aeb416fdaa41aab4ce7d4d59c8bc263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2012.06.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26437708$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22705382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuh, Bertram E</creatorcontrib><creatorcontrib>Nazmy, Michael</creatorcontrib><creatorcontrib>Ruel, Nora H</creatorcontrib><creatorcontrib>Jankowski, Jason T</creatorcontrib><creatorcontrib>Menchaca, Anita R</creatorcontrib><creatorcontrib>Torrey, Robert R</creatorcontrib><creatorcontrib>Linehan, Jennifer A</creatorcontrib><creatorcontrib>Lau, Clayton S</creatorcontrib><creatorcontrib>Chan, Kevin G</creatorcontrib><creatorcontrib>Wilson, Timothy G</creatorcontrib><title>Standardized Analysis of Frequency and Severity of Complications After Robot-assisted Radical Cystectomy</title><title>European urology</title><addtitle>Eur Urol</addtitle><description>Abstract Background Comprehensive and standardized reporting of adverse events after robot-assisted radical cystectomy (RARC) and urinary diversion for bladder cancer is necessary to evaluate the magnitude of morbidity for this complex operation. Objective To accurately identify and assess postoperative morbidity after RARC using a standardized reporting system. Design, setting, and participants A total of 241 consecutive patients underwent RARC, extended pelvic lymph node dissection, and urinary diversion between 2003 and 2011. In all, 196 patients consented to a prospective database, and they are the subject of this report. Continent diversions were performed in 68% of cases. Outcome measurements and statistical analysis All complications within 90 d of surgery were defined and categorized by a five-grade and 10-domain modification of the Clavien system. Univariable and multivariable logistic regression analyses were used to identify predictors of complications. Grade 1–2 complications were categorized as minor, and grade 3–5 complications were categorized as major. All blood transfusions were recorded as grade ≥2. Results and limitations Eighty percent of patients (156 of 196 patients) experienced a complication of any grade ≤90 d after surgery. A total of 475 adverse events (113 major) were recorded, with 365 adverse events (77%) occurring ≤30 d after surgery. Sixty-eight patients (35%) experienced a major complication within the first 90 d. Other than blood transfusions given (86 patients [43.9%]), infectious, gastrointestinal, and procedural complications were the most common, at 16.2%, 14.1%, and 10.3%, respectively. Age, comorbidity, preoperative hematocrit, estimated blood loss, and length of surgery were predictive of a complication of any grade, while comorbidity, preoperative hematocrit, and orthotopic diversion were predictive of major complications. The 90-d mortality rate was 4.1%. The main limitation is lack of a control group. Conclusions Analysis of postoperative morbidity following RARC demonstrates a considerable complication rate, though the rate is comparable to contemporary open series that followed similar reporting guidelines. This finding reinforces the need for complete and standardized reporting when evaluating surgical techniques and comparing published series.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Bladder cancer</subject><subject>Blood Transfusion</subject><subject>Chi-Square Distribution</subject><subject>Comorbidity</subject><subject>Complications</subject><subject>Cystectomy</subject><subject>Cystectomy - adverse effects</subject><subject>Cystectomy - methods</subject><subject>Cystectomy - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Logistic Models</subject><subject>Lymph Node Excision - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Postoperative Complications - diagnosis</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - mortality</subject><subject>Postoperative Complications - therapy</subject><subject>Research Design - standards</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Robotic</subject><subject>Robotics</subject><subject>Severity of Illness Index</subject><subject>Surgery, Computer-Assisted - adverse effects</subject><subject>Surgery, Computer-Assisted - mortality</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Tumors of the urinary system</subject><subject>Urinary Bladder Neoplasms - mortality</subject><subject>Urinary Bladder Neoplasms - surgery</subject><subject>Urinary Diversion - adverse effects</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><subject>Urinary tract. Prostate gland</subject><subject>Urology</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2LFDEQhoMo7uzqPxDpi-Cl20rSH-mLMAyuKywIO3oO-cSMPZ0x6V5of73VzKjgxVMIed5K5UkR8opCRYG27w6Vm9OcYsWAsgraCqB7QjZUdLzsmhaekg1wYCUTXFyR65wPAMCbnj8nV4x10HDBNuTbflKjVcmGn84W21ENSw65iL64Te7H7EazFAgUe_foUpiW9WQXj6chGDWFOOZi6yeXioeo41SqjOEJCz0oi8BQ7BbcmikelxfkmVdDdi8v6w35evvhy-6uvP_88dNue1-ahvKp9KCF70Wte68bTTU0glHttRW6Mdr0NVdO17T1VqmaKqVr4zpb26Y3QhvW8hvy9lz3lCL2nyd5DNm4YVCji3OWFHpe90Brjmh9Rk2KOSfn5SmFo0oLQnJ1LA_y7FiujiW0Eh1j7PXlhlkfnf0T-i0VgTcXQGWU4JMaTch_ubbmXQcCufdnzqGPx-CSzCagcWdDQmnSxvC_Tv4tYIYwruK_u8XlQ5wTfii-WWbMyP06D-s4UIZpwEH5BZuts9E</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Yuh, Bertram E</creator><creator>Nazmy, Michael</creator><creator>Ruel, Nora H</creator><creator>Jankowski, Jason T</creator><creator>Menchaca, Anita R</creator><creator>Torrey, Robert R</creator><creator>Linehan, Jennifer A</creator><creator>Lau, Clayton S</creator><creator>Chan, Kevin G</creator><creator>Wilson, Timothy G</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121101</creationdate><title>Standardized Analysis of Frequency and Severity of Complications After Robot-assisted Radical Cystectomy</title><author>Yuh, Bertram E ; Nazmy, Michael ; Ruel, Nora H ; Jankowski, Jason T ; Menchaca, Anita R ; Torrey, Robert R ; Linehan, Jennifer A ; Lau, Clayton S ; Chan, Kevin G ; Wilson, Timothy G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-f0b8f984b9fb5b1b05821bfbd8b5cbc943aeb416fdaa41aab4ce7d4d59c8bc263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Bladder cancer</topic><topic>Blood Transfusion</topic><topic>Chi-Square Distribution</topic><topic>Comorbidity</topic><topic>Complications</topic><topic>Cystectomy</topic><topic>Cystectomy - adverse effects</topic><topic>Cystectomy - methods</topic><topic>Cystectomy - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Logistic Models</topic><topic>Lymph Node Excision - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Postoperative Complications - diagnosis</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - mortality</topic><topic>Postoperative Complications - therapy</topic><topic>Research Design - standards</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Robotic</topic><topic>Robotics</topic><topic>Severity of Illness Index</topic><topic>Surgery, Computer-Assisted - adverse effects</topic><topic>Surgery, Computer-Assisted - mortality</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Tumors of the urinary system</topic><topic>Urinary Bladder Neoplasms - mortality</topic><topic>Urinary Bladder Neoplasms - surgery</topic><topic>Urinary Diversion - adverse effects</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><topic>Urinary tract. Prostate gland</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuh, Bertram E</creatorcontrib><creatorcontrib>Nazmy, Michael</creatorcontrib><creatorcontrib>Ruel, Nora H</creatorcontrib><creatorcontrib>Jankowski, Jason T</creatorcontrib><creatorcontrib>Menchaca, Anita R</creatorcontrib><creatorcontrib>Torrey, Robert R</creatorcontrib><creatorcontrib>Linehan, Jennifer A</creatorcontrib><creatorcontrib>Lau, Clayton S</creatorcontrib><creatorcontrib>Chan, Kevin G</creatorcontrib><creatorcontrib>Wilson, Timothy G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuh, Bertram E</au><au>Nazmy, Michael</au><au>Ruel, Nora H</au><au>Jankowski, Jason T</au><au>Menchaca, Anita R</au><au>Torrey, Robert R</au><au>Linehan, Jennifer A</au><au>Lau, Clayton S</au><au>Chan, Kevin G</au><au>Wilson, Timothy G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Standardized Analysis of Frequency and Severity of Complications After Robot-assisted Radical Cystectomy</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>62</volume><issue>5</issue><spage>806</spage><epage>813</epage><pages>806-813</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><coden>EUURAV</coden><abstract>Abstract Background Comprehensive and standardized reporting of adverse events after robot-assisted radical cystectomy (RARC) and urinary diversion for bladder cancer is necessary to evaluate the magnitude of morbidity for this complex operation. Objective To accurately identify and assess postoperative morbidity after RARC using a standardized reporting system. Design, setting, and participants A total of 241 consecutive patients underwent RARC, extended pelvic lymph node dissection, and urinary diversion between 2003 and 2011. In all, 196 patients consented to a prospective database, and they are the subject of this report. Continent diversions were performed in 68% of cases. Outcome measurements and statistical analysis All complications within 90 d of surgery were defined and categorized by a five-grade and 10-domain modification of the Clavien system. Univariable and multivariable logistic regression analyses were used to identify predictors of complications. Grade 1–2 complications were categorized as minor, and grade 3–5 complications were categorized as major. All blood transfusions were recorded as grade ≥2. Results and limitations Eighty percent of patients (156 of 196 patients) experienced a complication of any grade ≤90 d after surgery. A total of 475 adverse events (113 major) were recorded, with 365 adverse events (77%) occurring ≤30 d after surgery. Sixty-eight patients (35%) experienced a major complication within the first 90 d. Other than blood transfusions given (86 patients [43.9%]), infectious, gastrointestinal, and procedural complications were the most common, at 16.2%, 14.1%, and 10.3%, respectively. Age, comorbidity, preoperative hematocrit, estimated blood loss, and length of surgery were predictive of a complication of any grade, while comorbidity, preoperative hematocrit, and orthotopic diversion were predictive of major complications. The 90-d mortality rate was 4.1%. The main limitation is lack of a control group. Conclusions Analysis of postoperative morbidity following RARC demonstrates a considerable complication rate, though the rate is comparable to contemporary open series that followed similar reporting guidelines. This finding reinforces the need for complete and standardized reporting when evaluating surgical techniques and comparing published series.</abstract><cop>Kidlington</cop><pub>Elsevier B.V</pub><pmid>22705382</pmid><doi>10.1016/j.eururo.2012.06.007</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0302-2838 |
ispartof | European urology, 2012-11, Vol.62 (5), p.806-813 |
issn | 0302-2838 1873-7560 |
language | eng |
recordid | cdi_proquest_miscellaneous_1093490143 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aged Biological and medical sciences Bladder cancer Blood Transfusion Chi-Square Distribution Comorbidity Complications Cystectomy Cystectomy - adverse effects Cystectomy - methods Cystectomy - mortality Female Humans Incidence Logistic Models Lymph Node Excision - adverse effects Male Medical sciences Middle Aged Multivariate Analysis Nephrology. Urinary tract diseases Postoperative Complications - diagnosis Postoperative Complications - epidemiology Postoperative Complications - mortality Postoperative Complications - therapy Research Design - standards Retrospective Studies Risk Assessment Risk Factors Robotic Robotics Severity of Illness Index Surgery, Computer-Assisted - adverse effects Surgery, Computer-Assisted - mortality Time Factors Treatment Outcome Tumors of the urinary system Urinary Bladder Neoplasms - mortality Urinary Bladder Neoplasms - surgery Urinary Diversion - adverse effects Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Urology |
title | Standardized Analysis of Frequency and Severity of Complications After Robot-assisted Radical Cystectomy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A29%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Standardized%20Analysis%20of%20Frequency%20and%20Severity%20of%20Complications%20After%20Robot-assisted%20Radical%20Cystectomy&rft.jtitle=European%20urology&rft.au=Yuh,%20Bertram%20E&rft.date=2012-11-01&rft.volume=62&rft.issue=5&rft.spage=806&rft.epage=813&rft.pages=806-813&rft.issn=0302-2838&rft.eissn=1873-7560&rft.coden=EUURAV&rft_id=info:doi/10.1016/j.eururo.2012.06.007&rft_dat=%3Cproquest_cross%3E1093490143%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1093490143&rft_id=info:pmid/22705382&rft_els_id=S0302283812007087&rfr_iscdi=true |